Skip to main content
. 2023 May 29;15(6):1611. doi: 10.3390/pharmaceutics15061611

Figure 5.

Figure 5

Major categories of nanoparticle-based delivery systems in phytopharmaceutical formulations and their characteristics. Data from 164, 171, 176, and 182, and the figure was created with BioRender.com.